Outcome of the Board Meeting - Unaudited Financial results for quarter ended 30.06.2025
Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended 30.06.2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Results - Unaudited Financial Results For The Quarter Ended 30.06.2025
- Vista Pharmaceuticals Ltd. Press Release Aug 06 2025
- Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2025
- Vista Pharmaceuticals Ltd. Press Release Jul 16 2025
- Outcome Of Circular Resolution Passed By Board Of Directors Of The Company By Circulation On July 16, 2025 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Later from Vista Pharmaceuticals
- Re-Appointment Of Mr. Dhananjaya Alli (DIN: 00610909) As An Whole Time Director Of The Company
- Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The Company
- Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing Director Of The Company
- Vista Pharmaceuticals Ltd. Press Release Aug 13 2025
- 34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, 30Th September 2025
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals